trade premium food group share ytd
often hear investor stock alreadi well own admittedli although
reinvest year seem ahead peer journey
sustain profit top-lin growth view fact mdlz guidanc
call yoy organ sale growth -- consensu midpoint vs
expect yoy growth averag across peer said believ
could outperform expect would highlight yoy organ sale
forecast -- ultim could lead re-rat share view
recal provid guidanc key unknown
broader macro environ brexit emerg market still earli
year would surpris volum elast larg play
expect fact north america mdlz sale nielsen data would seem
suggest volum acceler price held steadi see figur
page regard north america suppli chain would highlight mdlz
indic confer call sign stabil servic
level market share trend solid heard noth increment less posit
cagni although continu believ recoveri wont linear lastli
believ emerg market continu track healthi msd yoy pace averag
mind would surpris mdlz organ top-lin growth
approach yoy key view investor start
appreci possibl sustain top-lin growth line mdlz long-
term algorithm yoy believ share could still re-rat closer
multi-national peer fact cl pg ko yoy organ top-lin
growth profil trade averag price-to-earnings multipl math three
turn recogn could well take coupl quarter
investor becom increasingli confid around mdlz top-lin momentum
believ share still compel stori stage
pt
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
overweight continu recommend
share given long-term potenti compani
deliv peer-lead sale earn growth
compani strateg option rel
valuat believ upsid
assum robust top-lin earn growth
along benefit fx see upsid
ep potenti appli price-to-earnings
multipl impli upsid valu
assum challeng organ sale backdrop
less favor fx less meaning margin
expans see potenti downsid
ep estim appli price-to-earnings multipl
impli downsid valu
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
thing come three
trade premium packag food group share
year date often hear investor stock alreadi well own admittedli
although reinvest year seem ahead peer
journey sustain profit top-lin growth view fact mdlz
guidanc call organ sale growth yoy rang -- consensu
midpoint vs expect yoy growth averag across large-cap peer see
figur said believ could well outperform expect
would highlight yoy organ sale forecast -- ultim could lead
re-rat share view
consensu current forecast yoy organ sale growth
higher end large-cap peer well yoy averag
recal provid guidanc key unknown
volum elast given mdlz price action north america suppli chain recoveri
broader macro environ brexit emerg market still earli year
would surpris volum elast larg play expect fact
north america mdlz sale nielsen data would seem suggest volum
acceler price/mix held steadi see figur
math past month roll twelv week basi volum growth acceler price/mix
growth held steadi recent twelv week data suggest volum elast
meanwhil regard north america suppli chain would highlight
note confer call sign stabil servic level
market share trend solid heard noth increment less posit cagni
though continu believ recoveri wont linear lastli believ emerg
market continu track healthi msd yoy pace averag
mind would surpris mdlz organ top-lin growth approach
yoy key view investor start appreci
possibl sustain top-lin growth line mdlz long-term algorithm
yoy believ share could still re-rat closer multi-national peer fact
cl pg ko yoy organ top-lin growth profil trade
averag price-to-earnings multipl math three turn current trade
math key multi-n peer yoy organ sale growth profil
trade averag price-to-earnings multipl roughli three turn
recogn could well take coupl quarter investor becom
increasingli confid around mdlz top-lin momentum believ share still
compel stori stage
stock
said continu look ep high end mdlz yoy
constant fx guidanc rang includ fx headwind rais price
target would surpris yoy organ sale growth
high end mdlz full year yoy guidanc rang come focu
year unfold price target repres price-to-earnings multipl
unchang ep estim premium group -- frankli
believ merit given mdlz top-lin momentum advantag categori
previous price target predic price-to-earnings multipl ep
estim
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
